CONVERSION TO EVEROLIMUS-BASED IMMUNOSUPPRESSION IN MAINTENANCE LIVER TRANSPLANT PATIENTS: RESULTS FROM 94 PATIENTS

被引：0
|
作者：
Vallin, Melanie [1 ]
Guillaud, Olivier [1 ]
Morard, Isabelle [2 ]
Gagnieu, Marie-Claude [1 ]
Mentha, Gilles [2 ]
Adham, Mustapha [1 ]
Morelon, Emmanuel [1 ]
Giostra, Emile [2 ]
Boillot, Olivier [1 ]
Dumortier, Jerome [1 ]
机构：
[1] Hop Edouard Herriot, Liver Transplant Unit, Lyon, France
[2] Hop Cantonal Univ Geneva, Liver Transplant Unit, Geneva, Switzerland
来源：
TRANSPLANT INTERNATIONAL | 2009年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：120 / 120
页数：1
相关论文
共 50 条
  • [21] Conversion to Everolimus in Liver Transplant Patients With Renal Dysfunction
    Perez, T.
    Segovia, R.
    Castro, L.
    Roblero, J. P.
    Estela, R.
    TRANSPLANTATION PROCEEDINGS, 2011, 43 (06) : 2307 - 2310
  • [22] Use of Everolimus-based Immunosuppression to Decrease Cytomegalovirus Infection After Kidney Transplant
    Malvezzi, Paolo
    Jouve, Thomas
    Rostaing, Lionel
    Experimental and Clinical Transplantation, 2016, 14 (04) : 361 - 366
  • [23] Everolimus-Based Immunosuppression in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Liver Transplantation: A Case Series
    Ferreiro, A. O.
    Vazquez-Millan, M. A.
    Lopez, F. S.
    Gutierrez, M. G.
    Diaz, S. P.
    Patino, M. J. L.
    TRANSPLANTATION PROCEEDINGS, 2014, 46 (10) : 3496 - 3501
  • [24] EVEROLIMUS-BASED IMMUNOSUPPRESSION IN HCV POSITIVE DE NOVO LIVER TRANSPLANT RECIPIENTS: 24-MONTH RESULTS OF A RANDOMIZED CONTROLLED TRIAL
    Saliba, F.
    Metselaar, H. J.
    Beckebaum, S.
    Duvoux, C.
    Navasa, M.
    Dong, G.
    Lopez, P.
    Nevens, F.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S79 - S80
  • [25] EVEROLIMUS AS PRIMARY IMMUNOSUPPRESSANT IN MAINTENANCE LIVER TRANSPLANT PATIENTS: 6-MONTH RESULTS
    De Simone, Paolo
    Precisi, Arianna
    Carrai, Paola
    Petruccelli, Stefania
    Balzano, Emanuele
    Coletti, Laura
    Catalano, Gabriele
    Filipponi, Franco
    LIVER TRANSPLANTATION, 2008, 14 (07) : S112 - S113
  • [26] Psychiatric Morbidity in De Novo Heart Transplant Recipients on Everolimus-Based Immunosuppression
    Buerker, B. S.
    Malt, U. F.
    Gude, E.
    Gullestad, L.
    Relbo, A.
    Grov, I.
    Andreassen, A. K.
    Fiane, A. E.
    Haraldsen, I. R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04): : S288 - S289
  • [27] LATE CONVERSION TO EVEROLIMUS IN MAINTENANCE LIVER TRANSPLANT PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Rassameehiran, Supannee
    Leelasinjaroen, Pornchai
    Tetangco, Eula
    GASTROENTEROLOGY, 2018, 154 (06) : S1147 - S1147
  • [28] Ab initio Everolimus-Based vs. Standard CNI Immunosuppression-Regimen in Liver Transplant Recipients
    Manzia, Tommaso Maria
    Quaranta, Claudia
    Toti, Luca
    Sforza, Daniele
    Pellicciaro, Marco
    Vella, Ivan
    Tariciotti, Laura
    Tisone, Giuseppe
    TRANSPLANTATION, 2018, 102 : S384 - S384
  • [29] Renal Function Outcomes in Kidney Transplant Recipients After Conversion to Everolimus-Based Immunosuppression Regimen with CNI Reduction or Elimination
    Cataneo-Davila, A.
    Zuniga-Varga, J.
    Correa-Rotter, R.
    Alberu, J.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (10) : 4138 - 4146
  • [30] Renal Preservation with Belatacept-Based versus Everolimus-Based Immunosuppression in Lung Transplant Recipients
    Sartain, E.
    Schoeppler, K.
    Crowther, B.
    Smith, J.
    Gray, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 383 - 383
12345